JAVMA news
FDA clarifies use of monensin
Rumensin is the first approved new animal drug feed ingredient for dairy cows that increases milk production.
JAVMA news
The ProHeart debate
In January, the Food and Drug Administration's Veterinary Medicine Advisory Committee and consultants heard presentations
JAVMA news
Drug-related positions approved
The Executive Board approved two new position statements, three revised positions, and rescission of an existing position
JAVMA news
Reminder: extralabel drug use of sulfonamides in lactating dairy cattle prohibited
The Food and Drug Administration's Center for Veterinary Medicine reminds veterinarians that extralabel use of sulfonamides is prohibited.
JAVMA news
Internet drug sales to U.S. pet owners questioned
The AVMA occasionally receives questions from veterinarians who believe their clients have purchased—without their
JAVMA news
Revised guide to drug, vaccine, pesticide use in aquaculture available
The revised edition of the popular Guide to Drug, Vaccine, and Pesticide Use in Aquaculture is now available as a Web document
JAVMA news
Move follows AABP conference
The American Association of Bovine Practitioners moved its headquarters from Georgia to Alabama
JAVMA news
Compounding Resources will educate veterinary profession
In recent months, the Food and Drug Administration has been cracking down on illegal drug compounding.
JAVMA news
When can a veterinarian import a foreign drug?
 NOTE: Please see Oct. 15, 2009, JAVMA News article, "FDA no longer issuing letters for importation for unapproved animal drugs," for…
JAVMA news
FDA stops use of enrofloxacin for bacterial infections in poultry
The Food and Drug Administration announced it would no longer allow distribution or use of the antimicrobial enrofloxacin after
JAVMA news
Riddell named to lead AABP
Dr. M. Gatz Riddell Jr. was named to the position by the AABP board of directors Feb. 12 during a special meeting in Atlanta.
JAVMA news
Battles over compounding from bulk drugs move forward
Animal drug compounding from bulk drug substances has become a heated issue since the Food and Drug Administration